AA
GILD icon

Addison Advisors’s Gilead Sciences GILD Stock Holding History

Addison Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.5K Sell
352
-509
-59% -$67.1K 0.02% 261
2026
Q1 		$120K Buy
861
+45
+6% +$6.3K 0.03% 293
2025
Q4 		$100K Buy
816
+29
+4% +$3.52K 0.02% 316
2025
Q3 		$87.4K Buy
787
+43
+6% +$4.89K 0.02% 337
2025
Q2 		$82.5K Sell
744
-19
-2% -$2.02K 0.02% 332
2025
Q1 		$85.5K Sell
763
-2
-0.3% -$206 0.02% 320
2024
Q4 		$70.7K Buy
765
+88
+13% +$7.92K 0.02% 340
2024
Q3 		$56.8K Buy
677
+203
+43% +$15.5K 0.02% 372
2024
Q2 		$32.5K Buy
474
+97
+26% +$6.47K 0.01% 421
2024
Q1 		$27.6K Sell
377
-126
-25% -$9.69K 0.01% 433
2023
Q4 		$40.7K Buy
503
+80
+19% +$6.22K 0.02% 383
2023
Q3 		$31.7K Sell
423
-141
-25% -$10.8K 0.01% 372
2023
Q2 		$43.5K Buy
564
+35
+7% +$2.79K 0.02% 336
2023
Q1 		$43.9K Sell
529
-18
-3% -$1.49K 0.02% 312
2022
Q4 		$47K Buy
547
+9
+2% +$713 0.03% 295
2022
Q3 		$33K Buy
538
+17
+3% +$1.07K 0.02% 300
2022
Q2 		$32K Buy
521
+35
+7% +$2.17K 0.02% 310
2022
Q1 		$29K Buy
486
+97
+25% +$6.2K 0.02% 354
2021
Q4 		$28K Buy
389
+131
+51% +$9.02K 0.02% 302
2021
Q3 		$18K Buy
258
+4
+2% +$281 0.01% 266
2021
Q2 		$17K Buy
+254
New +$17K 0.01% 268
2020
Q4 		$15K Buy
+254
New +$15.3K 0.01% 262

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Addison Advisors's GILD Position: Q2 2026 in Review

Addison Advisors reduced its Gilead Sciences (GILD) stake by 59% in Q2 2026, selling an estimated $67.1K and leaving 352 shares worth $44.5K. The position accounts for 0.02% of the portfolio, ranked #261.

Addison Advisors first reported a position in GILD in Q4 2020 and has held it in 22 quarters since. The position peaked at $120K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Addison Advisors held 352 shares of Gilead Sciences worth $44.5K as of Q2 2026.
  • Addison Advisors sold 509 Gilead Sciences shares in Q2 2026, an estimated $67.1K.
  • Gilead Sciences made up 0.02% of Addison Advisors's portfolio in Q2 2026, its #261 holding.
  • Addison Advisors first reported a position in Gilead Sciences in Q4 2020 and has held it in 22 quarters since.
  • Addison Advisors's Gilead Sciences position peaked at $120K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.